Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial
dc.contributor.author | Nelson, M.R. | |
dc.contributor.author | Polekhina, G. | |
dc.contributor.author | Woods, R.L. | |
dc.contributor.author | Reid, C.M. | |
dc.contributor.author | Tonkin, A.M. | |
dc.contributor.author | Wolfe, R. | |
dc.contributor.author | Murray, A.M. | |
dc.contributor.author | Kirpach, B. | |
dc.contributor.author | Ernst, M.E. | |
dc.contributor.author | Lockery, J.E. | |
dc.contributor.author | Shah, R.C. | |
dc.contributor.author | Stocks, N. | |
dc.contributor.author | Orchard, S.G. | |
dc.contributor.author | Zhou, Z. | |
dc.date.issued | 2022 | |
dc.description | Letters | |
dc.description.abstract | Abstract not available | |
dc.description.statementofresponsibility | Mark R. Nelson, Galina Polekhina, Robyn L. Woods, Christopher M. Reid, Andrew M. Tonkin, Rory Wolfe, Anne M. Murray, Brenda Kirpach, Michael E. Ernst, Jessica E. Lockery, Raj C. Shah, Nigel Stocks, Suzanne G. Orchard, Zhen Zhou | |
dc.identifier.citation | Annals of Internal Medicine, 2022; 175(5):1-4 | |
dc.identifier.doi | 10.7326/M21-3823 | |
dc.identifier.issn | 0003-4819 | |
dc.identifier.issn | 1539-3704 | |
dc.identifier.orcid | Stocks, N. [0000-0002-9018-0361] | |
dc.identifier.uri | https://hdl.handle.net/2440/134896 | |
dc.language.iso | en | |
dc.publisher | American College of Physicians | |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/334047 | |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1127060 | |
dc.rights | © 2022 American College of Physicians | |
dc.source.uri | https://doi.org/10.7326/m21-3823 | |
dc.subject | ASPREE randomized trial | |
dc.title | Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial | |
dc.type | Journal article | |
pubs.publication-status | Published |